title: Generation of conditional knockout alleles for PRL-3.
abstract: Phosphatase of regenerating liver-3 (PRL-3) is a member of the protein tyrosine phosphatase (PTP) superfamily and is highly expressed in cancer metastases. For better understanding of the role of PRL-3 in tumor metastasis, we applied a rapid and efficient method for generating PRL-3 floxed mice and investigated its phenotypes. A BAC retrieval strategy was applied to construct the PRL-3 conditional gene-targeting vector. Exon 4 was selected for deletion to generate a nonfunctional prematurely terminated short peptide as it will cause a frame-shift mutation. Conditional knockout PRL-3 mice were generated by using the Cre-loxP system and were validated by Southern blot and RT-PCR analysis. Further analysis revealed the phenotype characteristics of PRL-3 knockout mice and wildtype mice. In this study, we successfully constructed the PRL-3 conditional knockout mice, which will be helpful to clarify the roles of PRL-3 and the mechanisms in tumor metastasis.
authors.affiliation: Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing Medical University, Nanjing, Jiangsu 210029, China; ; Model Animal Research Center, Nanjing University, Nanjing, Jiangsu 210093, China.
authors.forename: Hong
authors.initials: H
authors.lastname: Yan
authors.forename: Dong
authors.initials: D
authors.lastname: Kong
authors.forename: Xiaomei
authors.initials: X
authors.lastname: Ge
authors.forename: Xiang
authors.initials: X
authors.lastname: Gao
authors.forename: Xiao
authors.initials: X
authors.lastname: Han
keywords: Cre recombinase; PRL-3; conditional knockout alleles; tumor metastasis
references.citation: Nat Rev Cancer. 2006 Apr;6(4):307-20
references.pmid: 16557282
references.citation: Virchows Arch. 2007 Mar;450(3):303-10
references.pmid: 17235563
references.citation: Biochem Biophys Res Commun. 2006 Sep 15;348(1):229-37
references.pmid: 16875667
references.citation: Genome Res. 2003 Mar;13(3):476-84
references.pmid: 12618378
references.citation: Pathobiology. 2004;71(4):176-84
references.pmid: 15263806
references.citation: Cancer Res. 2003 Jun 1;63(11):2716-22
references.pmid: 12782572
references.citation: J Cancer Res Clin Oncol. 2004 Sep;130(9):521-6
references.pmid: 15133662
references.citation: Biochem Biophys Res Commun. 1998 Mar 17;244(2):421-7
references.pmid: 9514946
references.citation: Clin Cancer Res. 2003 Nov 15;9(15):5607-15
references.pmid: 14654542
references.citation: Zhonghua Wei Chang Wai Ke Za Zhi. 2005 May;8(3):237-40
references.pmid: 16167237
references.citation: Mol Cancer Ther. 2005 Nov;4(11):1653-61
references.pmid: 16275986
references.citation: Acta Pharmacol Sin. 2004 Dec;25(12):1659-65
references.pmid: 15569412
references.citation: Cancer Res. 2007 Apr 1;67(7):2922-6
references.pmid: 17409395
references.citation: Ann Thorac Cardiovasc Surg. 2007 Aug;13(4):236-9
references.pmid: 17717498
references.citation: Am J Pathol. 2004 Jun;164(6):2039-54
references.pmid: 15161639
references.citation: J Biol Chem. 2000 Jul 14;275(28):21444-52
references.pmid: 10747914
references.citation: Science. 2001 Nov 9;294(5545):1343-6
references.pmid: 11598267
references.citation: Blood. 2008 Jan 15;111(2):806-15
references.pmid: 17934070
references.citation: Genomics. 2001 Apr 1;73(1):56-65
references.pmid: 11352566
references.citation: Int J Colorectal Dis. 2007 Oct;22(10):1179-84
references.pmid: 17440740
references.citation: Mol Cancer. 2009 Nov 24;8:110
references.pmid: 19930715
references.citation: Mol Cell Biol. 1994 Jun;14(6):3752-62
references.pmid: 8196618